# MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

> **NCT06815289** · NA · RECRUITING · sponsor: **University of Zurich** · enrollment: 11 (estimated)

## Conditions studied

- Primary Lung Cancer or Secondary Lung Metastases

## Interventions

- **RADIATION:** MR-informed stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT06815289
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815289, "MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06815289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*